As a camp counselor for children with disabilities a couple years ago, I never stopped to consider that one of my bipolar campers may have been on eight different kinds of medication.

A newly released study indicates that Vytorin, an expensive new cholesterol drug, is no more effective than an older drug Zocor. Although the drug makers got these results in April 2006, they failed to release them to doctors and the public--meanwhile earning $5 billion in revenue from sales of this drug last year. Sadly, we’re not shocked.

The New England Journal of Medicine issued a report that said a third of FDA-registered studies on popular antidepressants went unpublished.

If you ignore the plethora of drug ads on TV, you might want to check your email.

If you are poor, uninsured, non-English speaking, or an ethnic or racial minority, you are less likely to receive free drug samples, according to a first of its kind study by Harvard researchers at the Cambridge Health Alliance.